AQR Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $536K | Sell |
47,413
-8,562
| -15% | -$96.8K | ﹤0.01% | 2583 |
|
|
2025
Q1 | $646K | Buy |
+55,975
| New | +$646K | ﹤0.01% | 2278 |
|
|
2024
Q4 | – | Sell |
-12,354
| Closed | -$143K | – | 2906 |
|
|
2024
Q3 | $143K | Buy |
+12,354
| New | +$143K | ﹤0.01% | 2619 |
|
|
2024
Q2 | – | Sell |
-10,538
| Closed | -$125K | – | 2639 |
|
|
2024
Q1 | $125K | Buy |
+10,538
| New | +$125K | ﹤0.01% | 2316 |
|
|
2023
Q2 | – | Sell |
-21,848
| Closed | -$172K | – | 2235 |
|
|
2023
Q1 | $172K | Sell |
21,848
-72,436
| -77% | -$569K | ﹤0.01% | 2075 |
|
|
2022
Q4 | $637K | Buy |
+94,284
| New | +$637K | ﹤0.01% | 1724 |
|